Diagnostic Yield Improves With Collection of 2 Samples in Fecal Immunochemical Test Screening Without Affecting Attendance

Clinical Gastroenterology and Hepatology

Volumn 9, Issue 4, 2011, Pages 333-339

  van Roon, Aafke H C ^a   Wilschut, Janneke A ^a   Hol, Lieke ^a   van Ballegooijen, Marjolein ^a   Reijerink, Jacqueline C I Y ^b   't Mannetje, Hans ^b   Kranenburg, Laura J C ^a   Biermann, Katharina ^a   van Vuuren, Anneke J ^a   Francke, Jan ^a   van der Togt, Alexandra C M ^c   Habbema, Dik J F ^a   van Leerdam, Monique E ^a   Kuipers, Ernst J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Association of Nationwide Screening for the Southwestern Netherlands   (United States)

^c Integraal Kankercentrum Rotterdam   (Netherlands)

Author keywords

Cancer Screening; Colon Cancer; Multiple Samples; Noninvasive Tests

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; HUMAN; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; OCCULT BLOOD TEST; SCREENING TEST;

AGED; CLINICAL LABORATORY TECHNIQUES; FECES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBINS; HUMANS; IMMUNOCHEMISTRY; MALE; MASS SCREENING; MIDDLE AGED; RANDOM ALLOCATION; SENSITIVITY AND SPECIFICITY;

EID: 79952835583     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.12.012     Document Type: Article

References (18)

1. Center M.M., Jemal A., Smith R.A., et al. Worldwide variations in colorectal cancer. CA Cancer J Clin 2009, 59:366-378.
2. O'Connell J.B., Maggard M.A., Ko C.Y. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004, 96:1420-1425.
3. Winawer S.J., Zauber A.G., Ho M.N., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993, 329:1977-1981.
4. Hewitson P., Glasziou P., Watson E., et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008, 103:1541-1549.
5. Guittet L., Bouvier V., Mariotte N., et al. Comparison of a guaiac and an immunochemical faecal occult blood test for the detection of colonic lesions according to lesion type and location. Br J Cancer 2009, 100:1230-1235.
6. Hol L., van Leerdam M.E., van Ballegooijen M., et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010, 59:62-68.
7. Hol L., Wilschut J.A., van Ballegooijen M., et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer 2009, 100:1103-1110.
8. van Rossum L.G., van Rijn A.F., Laheij R.J., et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008, 135:82-90.
9. Allison J.E., Sakoda L.C., Levin T.R., et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007, 99:1462-1470.
10. Guittet L., Bouvier V., Mariotte N., et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007, 56:210-214.
11. Schlemper R.J., Riddell R.H., Kato Y., et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000, 47:251-255.
12. Grazzini G., Visioli C.B., Zorzi M., et al. Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?. Br J Cancer 2009, 100:259-265.
13. Levi Z., Rozen P., Hazazi R., et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007, 146:244-255.
14. Park D.I., Ryu S., Kim Y.H., et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol 2010, 105:2017-2025.
15. Launoy G.D., Bertrand H.J., Berchi C., et al. Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population. Int J Cancer 2005, 115:493-496.
16. Allison J.E., Tekawa I.S., Ransom L.J., et al. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996, 334:155-159.
17. Guittet L., Bouvier V., Mariotte N., et al. Performance of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples. Int J Cancer 2009, 125:1127-1133.
18. Nakama H., Yamamoto M., Kamijo N., et al. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia. Hepatogastroenterology 1999, 46:228-231.